Does testosterone mediate the relationship between vitamin D and prostate cancer progression? A systematic review and meta-analysis

被引:0
作者
Luke A. Robles
Sean Harrison
Vanessa Y. Tan
Rhona Beynon
Alexandra McAleenan
Julian PT. Higgins
Richard M. Martin
Sarah J. Lewis
机构
[1] University of Bristol,Department of Population Health Sciences, Bristol Medical School
[2] University of Bristol,Medical Research Council Integrative Epidemiology Unit
[3] University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol,NIHR Bristol Biomedical Research Centre
来源
Cancer Causes & Control | 2022年 / 33卷
关键词
Vitamin D; Testosterone; Prostate cancer; Progression; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1025 / 1038
页数:13
相关论文
共 247 条
[1]  
Schröder FH(2009)Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 1320-1328
[2]  
Hugosson J(2018)Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis BMJ (Clin Res ed) 362 k3519-1424
[3]  
Roobol MJ(2016)10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer N Engl J Med 375 1415-2881
[4]  
Tammela TL(2009)Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review Cancer epidemiol biomarkers prev 18 2874-1379
[5]  
Ciatto S(2019)Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: The SUNSHINE randomized clinical trial JAMA 321 1370-1369
[6]  
Nelen V(2019)Effect of Vitamin D supplementation on relapse-free survival among patients with digestive tract cancers: the AMATERASU randomized clinical trial JAMA 321 1361-357
[7]  
Ilic D(2014)The role of vitamin D in reducing cancer risk and progression Nat Rev cancer 14 342-r303
[8]  
Djulbegovic M(2018)Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis Endocr connect 7 R294-2324
[9]  
Jung JH(2012)Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance J Clin Endocrinol Metab 97 2315-1507
[10]  
Hwang EC(2013)Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and Ki67 labeling in prostate cancer patients J Clin Endocrinol Metab 98 1498-1675